OFFICIAL PUBLICATION OF

by its subsidiary APPco

Research roundup

Debbie Rigby 23/11/2016

The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties of the sofosbuvir plus ledipasvir (SOF/LDV) fixed dose combination for the treatment of hepatitis C virus (HCV). The SOF/LDV fixed dose combination has good pharmacological

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Did wave of protest fail to break?

Coles and Woolies have been good for competition? Have you not followed the Senate inquiry into the supermarkets and how…

Bart Pharm

Pharmacy needs retention plan

But as an owner you would do quite well

Hery Briskin

Did wave of protest fail to break?

Or busy waging war against the ALP...

Morbidly Obese John

Did wave of protest fail to break?

The Pharmacy Guild has submitted a response on behalf of members to the ACCC’s review of the proposed merger of…

Anthony Tassone

Research roundup

Previous How agricultural antibiotic use affects resistance

Next Forum: Safety net delays By Medicare

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous How agricultural antibiotic use affects resistance

Next Forum: Safety net delays By Medicare

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.